IRadimed Corporation (IRMD) Earnings History
Annual and quarterly earnings data from 2012 to 2025
Loading earnings history...
IRMD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
IRMD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 76.7% | 31.2% | 26.8% |
| 2024 | 76.9% | 30.0% | 26.3% |
| 2023 | 76.5% | 30.6% | 26.2% |
| 2022 | 77.4% | 29.3% | 24.1% |
| 2021 | 76.6% | 23.5% | 22.3% |
Download Data
Export IRMD earnings history in CSV or JSON format
Free sign-in required to download data
IRadimed Corporation (IRMD) Earnings Overview
As of May 8, 2026, IRadimed Corporation (IRMD) reported trailing twelve-month net income of $24M, reflecting +16.7% year-over-year growth. The company earned $1.83 per diluted share over the past four quarters, with a net profit margin of 26.8%.
Looking at the long-term picture, IRMD's 5-year EPS compound annual growth rate (CAGR) stands at +73.9%, indicating exceptional earnings growth. The company achieved its highest annual net income of $22M in fiscal 2025, representing a new all-time high.
IRadimed Corporation maintains industry-leading profitability with a gross margin of 76.7%, operating margin of 31.2%, and net margin of 26.8%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including LNTH ($279M net income, 15.2% margin), PRCT (-$102M net income, -31.0% margin), ANGO (-$28M net income, -11.6% margin), IRMD has outperformed on profitability metrics. Compare IRMD vs LNTH →
IRMD Earnings vs Peers
Earnings metrics vs comparable public companies
IRMD Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $22M | +16.9% | $26M | $1.75 | 26.8% | 31.2% |
| 2024 | $19M | +11.9% | $22M | $1.50 | 26.3% | 30.0% |
| 2023 | $17M | +34.0% | $20M | $1.35 | 26.2% | 30.6% |
| 2022 | $13M | +37.6% | $16M | $1.02 | 24.1% | 29.3% |
| 2021 | $9M | +581.2% | $10M | $0.74 | 22.3% | 23.5% |
| 2020 | $1M | -85.8% | $-756,091 | $0.11 | 4.3% | -2.4% |
| 2019 | $10M | +52.8% | $9M | $0.78 | 25.0% | 22.5% |
| 2018 | $6M | +1161.3% | $6M | $0.52 | 20.7% | 19.7% |
| 2017 | $499,764 | -93.1% | $1M | $0.04 | 2.2% | 5.6% |
| 2016 | $7M | -4.2% | $11M | $0.60 | 22.2% | 33.6% |
See IRMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IRMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IRMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIRMD — Frequently Asked Questions
Quick answers to the most common questions about buying IRMD stock.
Is IRMD growing earnings?
IRMD EPS is $1.83, with earnings growth accelerating to +16.7%. This exceeds the 5-year CAGR of +73.9%. TTM net income reached $24M.
What are IRMD's profit margins?
IRadimed Corporation net margin is +26.8%, with operating margin at +31.2%. Above-average margins indicate pricing power.
How consistent are IRMD's earnings?
IRMD earnings data spans 2012-2025. The accelerating earnings trend is +16.7% YoY. Historical data enables comparison across business cycles.